Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LABA/ICS Effects on Exercise in Well-Trained Individuals
NCT06077019Recruiting
- Start
- Oct 2023
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in asthma comparing Vilanterol + Fluticasone Furoate, Indacaterol + Mometasone Furoate and Placebo (3 arms). Primary endpoint: Exercise capacity during a time trial at 8 weeks. Started Oct 2023; status: recruiting.
02
Drugs
vilanterolfluticasoneindacaterolmometasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06077019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06077019.